Recruitment

Recruitment Status
Completed
Estimated Enrollment
300

Summary

Conditions
  • Hypercholesterolemia, Familial
  • Hyperlipoproteinemia Type II
Type
Interventional
Phase
Phase 3
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Investigator)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 80 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT01524289
Collaborators
Not Provided
Investigators
Study Director: Medical Director Merck Sharp & Dohme Corp.